CentralReach Appoints David Stevens as First-Ever Head of Generative AI

What You Should Know:

– CentralReach, the leading provider of software for ABA and multi-disciplinary providers treating Autism and IDD, announced the appointment of David Stevens as its first-ever Head of GenerativeAI (GenAI).

– In this newly created role, Stevens will lead a team dedicated to designing, developing, and piloting GenAI features for CentralReach’s software suite, cari. The company currently boasts over 20 GenAI solutions in various stages of development, with a focus on streamlining workflows and improving financial outcomes for providers.

Eli Lilly boosts sales forecast by $3bn as diabetes and weight loss drugs propel revenue – Pharmaceutical Technology

Sales of diabetes drug Mounjaro totalled $3.1bn in Q2, compared to $979.7m in the same period last year. Image credit: Shutterstock/ Mohammed_Al_Ali. Eli Lilly has

August 9, 2024

GSK shares fall 9% in wake of Zantac court ruling – Pharmaceutical Technology

GSK pointed out that the latest ruling does not mean that the Court agrees with plaintiffs’ experts’ scientific conclusions, and it does not determine liability.

June 4, 2024

How health care organizations can set up chief medical officers for success

It should be obvious that medical school and clinical experience, in themselves, can’t fully prepare someone for the C-suite, any more than an MBA and

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.